Press Releases

May 1, 2019

FDA approves Dengvaxia® for the prevention of dengue in individuals ages 9 through 16 living in U.S. endemic areas
Apr 26, 2019

FDA approves Praluent® (alirocumab) to prevent heart attack, stroke and unstable angina requiring hospitalization

* Praluent is the first PCSK9 inhibitor that has shown a meaningful reduction in death from any cause
Apr 26, 2019

Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER
- Video 1
- Photos 4
Apr 10, 2019

Sanofi provides unprecedented access to its insulins for one set monthly price

* Sanofi continues its commitment to helping reduce cost burden for people living with diabetes with first-ever insulin savings program
- Photos 1
Mar 22, 2019

FDA issues Complete Response Letter for Zynquista™ (sotagliflozin)

Show per page

Print
Email page
RSS